Registry update — unassessed
Metformin and Vaccine Response in Older Adults
Trial registry update: COMPLETED. No results reported in the supplied registry record.
RCTMinor significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Aug 20, 2024 · Discovered: Sep 15, 2026 · Assessed: — · Historical research backfill
What it does not prove
- Whether metformin actually affects vaccine response is unknown—no results are reported
- No information on which older adults were studied or any baseline characteristics that might limit generalisability
- No data on safety, dosing, duration, or any measured immune outcomes
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- The University of Texas Health Science Center at San Antonio
- Published
- Aug 20, 2024
Sources
Primary source
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
To determine whether metformin (MET) can improve the immune response to the pneumococcal conjugate vaccine (PCV-13) in older adults.
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.